A Role for Exposed Mannosylations in Presentation of Human Therapeutic Self-proteins to Cd4+ T Lymphocytes.
From: Unité 872, Institut National de la Santé et de la Recherche Médicale, F-75006 Paris, France.
Proceedings of the National Academy of Sciences of the United States of America
- Publish Date: May 2007
- ISSN: 0027-8424
- Volume: 104
- Issue: 21
- Pages: 8965-70
- Medium: Print
- Language: English
- Citation (JAMA): Dasgupta Suryasarathi, Navarrete Ana-Maria, Bayry Jagadeesh, et al. A Role for Exposed Mannosylations in Presentation of Human Therapeutic Self-proteins to Cd4+ T Lymphocytes.. Proc. Natl. Acad. Sci. U.S.A. May 2007;104:8965-70
Abstract
Several therapeutic self-proteins elicit immune responses when administered to patients. Such adverse immune responses reduce drug efficacy. To induce an immune response, a protein must interact with different immune cells, including antigen-presenting cells, T cells, and B cells. Each cell type recognizes distinct immunogenic patterns on antigens. Mannose-terminating glycans have been identified as pathogen-associated molecular patterns that are essential for internalization of microbes by antigen-presenting cells, leading to presentation. Here, we have investigated the importance of exposed mannosylation on an immunogenic therapeutic self-protein, procoagulant human factor VIII (FVIII). Administration of therapeutic FVIII to hemophilia A patients induces inhibitory anti-FVIII antibodies in up to 30% of the cases. We demonstrate that entry of FVIII into human dendritic cells (DC) leading to T cell activation, is mediated by mannose-terminating glycans on FVIII. Further, we identified macrophage mannose receptor (CD206) as a candidate endocytic receptor for FVIII on DC. Saturation of mannose receptors on DC with mannan, and enzymatic removal of mannosylated glycans from FVIII lead to reduced T cell activation. The interaction between FVIII and CD206 was blocked by VWF, suggesting that, under physiological conditions, the intrinsic mannose-dependent immunogenicity of FVIII is quenched by endogenous immunochaperones. These data provide a link between the mannosylation of therapeutic self-proteins and their iatrogenic immunogenicity. Such a link would be of special relevance in the context of replacement therapy where mechanisms of central and peripheral tolerance have not been established during ontogeny because of the absence of the antigen.
Mesh Headings (Keywords): CD4-Positive T-Lymphocytes, Cells, Cultured, Dendritic Cells, Endocytosis, Factor VIII, Humans, Lectins, C-Type, Lymphocyte Activation, Mannose, Mannose-Binding Lectins, Polysaccharides, Protein Binding, Receptors, Cell Surface, von Willebrand Factor
Check for Full Text / PubMed Unique Identifier (PMID): 17502612
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.